Clinical Trials Directory

Trials / Completed

CompletedNCT01365390

To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries

To Evaluate Incidence of Acute Otitis Media in Children Aged < 6 Years in Five East European Countries

Status
Completed
Phase
Study type
Observational
Enrollment
2,258 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
6 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to provide baseline acute otitis media data in East European countries.

Detailed description

Each subject's involvement in this study will include a retrospective and prospective part.

Conditions

Interventions

TypeNameDescription
OTHERData collection (Retrospective)For the retrospective part of the study, the parent(s)/ legally acceptable representative(s) of the subjects will be interviewed to collect information on factors potentially related to risk for middle ear diseases. The medical records of the subjects will also be reviewed and all acute otitis media related problems that occurred during the last year prior to enrolment (for subjects aged 1 to \< 6 years) or since birth (for subjects aged \< 1 year) will be recorded in the electronic case report form.
OTHERData collection (Prospective)For the prospective part of the study, the enrolled subjects will be followed up for a period of 1 year starting from the consent date, during which the parent(s)/ legally acceptable representative(s) will be asked to bring the subject for a visit each time they notice symptoms of acute otitis media or respiratory tract infection in the subject. In case AOM is diagnosed by the investigator, detailed information on the signs, symptoms, severity, course and treatment will be recorded. The parent(s)/ legally acceptable representative(s) of the subjects will also be required to fill up a parental quality of life questionnaire and an Otitis Media-6 children's quality of life questionnaire.

Timeline

Start date
2011-06-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-06-03
Last updated
2014-07-28

Locations

25 sites across 5 countries: Estonia, Lithuania, Poland, Romania, Slovenia

Source: ClinicalTrials.gov record NCT01365390. Inclusion in this directory is not an endorsement.